Literature DB >> 18547946

WNK kinases, renal ion transport and hypertension.

Pedro San-Cristobal1, Paola de los Heros, José Ponce-Coria, Erika Moreno, Gerardo Gamba.   

Abstract

Two members of a recently discovered family of protein kinases are the cause of an inherited disease known as pseudohypoaldosteronism type II (PHAII). These patients exhibit arterial hypertension together with hyperkalemia and metabolic acidosis. This is a mirror image of Gitelman disease that is due to inactivating mutations of the SLC12A3 gene that encodes the thiazide-sensitive Na(+):Cl(-) cotransporter. The uncovered genes causing PHAII encode for serine/threonine kinases known as WNK1 and WNK4. Physiological and biochemical studies have revealed that WNK1 and WNK4 modulate the activity of several transport pathways of the aldosterone-sensitive distal nephron, thus increasing our understanding of how diverse renal ion transport proteins are coordinated to regulate normal blood pressure levels. Observations discussed in the present work place WNK1 and WNK4 as genes involved in the genesis of essential hypertension and as potential targets for the development of antihypertensive drugs. Copyright 2008 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18547946      PMCID: PMC2820349          DOI: 10.1159/000139639

Source DB:  PubMed          Journal:  Am J Nephrol        ISSN: 0250-8095            Impact factor:   3.754


  66 in total

1.  WNK1, a novel mammalian serine/threonine protein kinase lacking the catalytic lysine in subdomain II.

Authors:  B Xu; J M English; J L Wilsbacher; S Stippec; E J Goldsmith; M H Cobb
Journal:  J Biol Chem       Date:  2000-06-02       Impact factor: 5.157

Review 2.  Molecular mechanisms of human hypertension.

Authors:  R P Lifton; A G Gharavi; D S Geller
Journal:  Cell       Date:  2001-02-23       Impact factor: 41.582

3.  WNK4 regulates activity of the epithelial Na+ channel in vitro and in vivo.

Authors:  Aaron M Ring; Sam X Cheng; Qiang Leng; Kristopher T Kahle; Jesse Rinehart; Maria D Lalioti; Heather M Volkman; Frederick H Wilson; Steven C Hebert; Richard P Lifton
Journal:  Proc Natl Acad Sci U S A       Date:  2007-02-26       Impact factor: 11.205

4.  Functional expression of mutations in the human NaCl cotransporter: evidence for impaired routing mechanisms in Gitelman's syndrome.

Authors:  Joke C De Jong; Walter A Van Der Vliet; Lambertus P W J Van Den Heuvel; Peter H G M Willems; Nine V A M Knoers; René J M Bindels
Journal:  J Am Soc Nephrol       Date:  2002-06       Impact factor: 10.121

5.  Human hypertension caused by mutations in WNK kinases.

Authors:  F H Wilson; S Disse-Nicodème; K A Choate; K Ishikawa; C Nelson-Williams; I Desitter; M Gunel; D V Milford; G W Lipkin; J M Achard; M P Feely; B Dussol; Y Berland; R J Unwin; H Mayan; D B Simon; Z Farfel; X Jeunemaitre; R P Lifton
Journal:  Science       Date:  2001-08-10       Impact factor: 47.728

6.  WNK kinases, a novel protein kinase subfamily in multi-cellular organisms.

Authors:  F Veríssimo; P Jordan
Journal:  Oncogene       Date:  2001-09-06       Impact factor: 9.867

7.  Evidence for a gene influencing blood pressure on chromosome 17. Genome scan linkage results for longitudinal blood pressure phenotypes in subjects from the framingham heart study.

Authors:  D Levy; A L DeStefano; M G Larson; C J O'Donnell; R P Lifton; H Gavras; L A Cupples; R H Myers
Journal:  Hypertension       Date:  2000-10       Impact factor: 10.190

8.  Genetic heterogeneity of familial hyperkalaemic hypertension.

Authors:  S Disse-Nicodeme; I Desitter; B Fiquet-Kempf; A M Houot; N Stern; M Delahousse; J Potier; J L Ader; X Jeunemaitre
Journal:  J Hypertens       Date:  2001-11       Impact factor: 4.844

9.  A new locus on chromosome 12p13.3 for pseudohypoaldosteronism type II, an autosomal dominant form of hypertension.

Authors:  S Disse-Nicodème; J M Achard; I Desitter; A M Houot; A Fournier; P Corvol; X Jeunemaitre
Journal:  Am J Hum Genet       Date:  2000-06-22       Impact factor: 11.025

10.  Deafness and renal tubular acidosis in mice lacking the K-Cl co-transporter Kcc4.

Authors:  Thomas Boettger; Christian A Hübner; Hannes Maier; Marco B Rust; Franz X Beck; Thomas J Jentsch
Journal:  Nature       Date:  2002-04-25       Impact factor: 49.962

View more
  10 in total

1.  American Society of Nephrology Quiz and Questionnaire 2015: Electrolytes and Acid-Base Disorders.

Authors:  Mitchell H Rosner; Mark A Perazella; Michael J Choi
Journal:  Clin J Am Soc Nephrol       Date:  2016-01-29       Impact factor: 8.237

Review 2.  The thiazide-sensitive Na+-Cl- cotransporter: molecular biology, functional properties, and regulation by WNKs.

Authors:  Gerardo Gamba
Journal:  Am J Physiol Renal Physiol       Date:  2009-05-27

Review 3.  WNK kinases and blood pressure control.

Authors:  Staci L Deaton; Samarpita Sengupta; Melanie H Cobb
Journal:  Curr Hypertens Rep       Date:  2009-12       Impact factor: 5.369

Review 4.  Revisiting the NaCl cotransporter regulation by with-no-lysine kinases.

Authors:  Silvana Bazúa-Valenti; Gerardo Gamba
Journal:  Am J Physiol Cell Physiol       Date:  2015-03-18       Impact factor: 4.249

5.  A single residue in transmembrane domain 11 defines the different affinity for thiazides between the mammalian and flounder NaCl transporters.

Authors:  María Castañeda-Bueno; Norma Vázquez; Ismael Bustos-Jaimes; Damian Hernández; Erika Rodríguez-Lobato; Diana Pacheco-Alvarez; Raquel Cariño-Cortés; Erika Moreno; Norma A Bobadilla; Gerardo Gamba
Journal:  Am J Physiol Renal Physiol       Date:  2010-08-18

6.  Angiotensin II signaling increases activity of the renal Na-Cl cotransporter through a WNK4-SPAK-dependent pathway.

Authors:  Pedro San-Cristobal; Diana Pacheco-Alvarez; Ciaran Richardson; Aaron M Ring; Norma Vazquez; Fatema H Rafiqi; Divya Chari; Kristopher T Kahle; Qiang Leng; Norma A Bobadilla; Steven C Hebert; Dario R Alessi; Richard P Lifton; Gerardo Gamba
Journal:  Proc Natl Acad Sci U S A       Date:  2009-02-24       Impact factor: 11.205

7.  Activation of the renal Na+:Cl- cotransporter by angiotensin II is a WNK4-dependent process.

Authors:  María Castañeda-Bueno; Luz Graciela Cervantes-Pérez; Norma Vázquez; Norma Uribe; Sheila Kantesaria; Luciana Morla; Norma A Bobadilla; Alain Doucet; Dario R Alessi; Gerardo Gamba
Journal:  Proc Natl Acad Sci U S A       Date:  2012-05-01       Impact factor: 11.205

8.  Disruption of the with no lysine kinase-STE20-proline alanine-rich kinase pathway reduces the hypertension induced by angiotensin II.

Authors:  Luz G Cervantes-Perez; Maria Castaneda-Bueno; Jose V Jimenez; Norma Vazquez; Lorena Rojas-Vega; Dario R Alessi; Norma A Bobadilla; Gerardo Gamba
Journal:  J Hypertens       Date:  2018-02       Impact factor: 4.844

Review 9.  Genetics of hypertension: from experimental animals to humans.

Authors:  Christian Delles; Martin W McBride; Delyth Graham; Sandosh Padmanabhan; Anna F Dominiczak
Journal:  Biochim Biophys Acta       Date:  2009-12-24

10.  Chloride sensing by WNK1 regulates NLRP3 inflammasome activation and pyroptosis.

Authors:  Lindsey Mayes-Hopfinger; Aura Enache; Jian Xie; Chou-Long Huang; Robert Köchl; Victor L J Tybulewicz; Teresa Fernandes-Alnemri; Emad S Alnemri
Journal:  Nat Commun       Date:  2021-07-27       Impact factor: 14.919

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.